Uterine Cervical Incompetence
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes6
- Cervix Uteri1
- Cytokines1
- Immune Checkpoint Proteins1
- Microbiota1
- Premature Birth1
- Uterine Cervical Incompetence1
Leading journals1
- Frontiers in immunology1
Leading researchers8
- Cho WK1
- Choi SR1
- Jeon K1
- Jeong S1
- Jo Y1
- Lee KY1
- Lee N1
- Park MJ1
Affiliations (unnormalised)4
- College of Biotechnology and Bioengineering1
- Department of Laboratory Medicine1
- Inha University College of Medicine1
- Kangnam Sacred Heart Hospital1
Reference
Authoritative identity, definition & identifiers.
Incompetent UTERINE CERVIX is usually diagnosed in the second trimester of PREGNANCY. It is characterized by passive painless cervical dilation in the absence of UTERINE CONTRACTION; BLEEDING; INFECTION; and sometimes with the amniotic sac (AMNIOTIC MEMBRANE) bulging through the partially dilated cervix. Left untreated, this condition may lead to premature pregnancy loss, such as HABITUAL ABORTION.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.